Co-occurrence of Asthma and the Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis

Clinical and Translational Gastroenterology

Volumn 9, Issue 9, 2018, Pages

  Kuenzig, M Ellen ^a   Bishay, Kirles ^b   Leigh, Richard ^c   Kaplan, Gilaad G ^c,d   Benchimol, Eric I ^a,b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ASTHMA; CLINICAL FEATURE; CROHN DISEASE; DISEASE ASSOCIATION; HUMAN; INFLAMMATORY BOWEL DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; COMPLICATION; META ANALYSIS; ONSET AGE; TIME FACTOR;

AGE OF ONSET; ASTHMA; COLITIS, ULCERATIVE; CROHN DISEASE; HUMANS; RISK FACTORS; TIME FACTORS;

EID: 85053916026     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/s41424-018-0054-z     Document Type: Review

References (66)

1. de Souza, H. S. P. & Fiocchi, C. Immunopathogenesis of IBD: current state of the art. Nat. Rev. Gastroenterol. Hepatol. 13, 13–27 (2015).
2. Xiao, C. et al. Defective epithelial barrier function in asthma. J. Allergy Clin. Immunol. 128, 549–566 (2011).
3. Holgate, S. T. Epithelium dysfunction in asthma. J. Allergy Clin. Immunol. 120, 1233–1244 (2007).
4. Henderson, P. et al. Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease. Inflamm. Bowel Dis. 17, 382–395 (2011).
5. Hackett, T.-L. et al. Intrinsic phenotypic differences of asthmatic epithelium and its inflammatory responses to respiratory syncytial virus and air pollution. Am. J. Respir. Cell Mol. Biol. 45, 1090–1100 (2011).
6. Wark, P. A. B. et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J. Exp. Med. 201, 937–947 (2005).
7. Geremia, A. et al. Innate and adaptive immunity in inflammatory bowel disease. Autoimmun. Rev. 13, 3–10 (2014).
8. Frolkis, A. D. et al. Environment and the inflammatory bowel diseases. Can. J. Gastroenterol. 27, e18–e24 (2013).
9. Aujnarain, A., Mack, D. R. & Benchimol, E. I. The role of the environment in the development of pediatric inflammatory bowel disease topical collection on pediatric gastroenterology. Curr. Gastroenterol. Rep. 15, 326 (2013).
10. Dogaru, C. M. et al. Breastfeeding and childhood asthma: systematic review and meta-analysis. Am. J. Epidemiol. 179, 1153–1167 (2014).
11. Daley, D. The evolution of the hygiene hypothesis. Curr. Opin. Allergy Clin. Immunol. 14, 390–396 (2014).
12. Stiemsma, L. et al. The hygiene hypothesis: current perspectives and future therapies. Immunotargets Ther. 4, 143–157 (2015).
13. Lees, C. W. et al. New IBD genetics: common pathways with other diseases. Gut 60, 1739–1753 (2011).
14. Zhong, Y., Kinio, A. & Saleh, M. Functions of NOD-like receptors in human diseases. Front. Immunol. 4, 333 (2013).
15. Abdollahi, E. et al. Protective role of R381Q (rs11209026) polymorphism in IL-23Rgene in immune-mediated diseases: a comprehensive review. J. Immunotoxicol. 13, 286–300 (2015).
16. Molodecky, N. A. et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142, 46–54 (2012).
17. Kaplan, G. G. The global burden of IBD: from 2015 to 2025. Nat. Rev. Gastroenterol. Hepatol. 12, 720–727 (2015).
18. Benchimol, E. I. et al. Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends. Inflamm. Bowel Dis. 17, 423–439 (2011).
19. Masoli, M. et al. The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy 59, 469–478 (2004).
20. Ng, S. C. et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390, 2769–2778 (2018).
21. Su, X. et al. Prevalence of comorbidities in asthma and nonasthma patients. Medicine 95, e3459–7 (2016).
22. Kuenzig, M. E. et al. Asthma Is Associated With Subsequent Development of Inflammatory Bowel Disease: A Population-based Case-Control Study. Clin Gastroenterol Hepatol. 15, 1405–1412.e3 (2017).
23. Bernstein, C. N., Wajda, A. & Blanchard, J. F. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 129, 827–836 (2005).
24. Gearry, R. B. et al. Population-based cases control study of inflammatory bowel disease risk factors. J. Gastroenterol. Hepatol. 25, 325–333 (2010).
25. Kauppi, P. et al. Chronic comorbidities contribute to the burden and costs of persistent asthma. Mediat. Inflamm. 2015, 819194 (2015).
26. Virta, L. J., Ashorn, M. & Kolho, K.-L. Cowʼs milk allergy, asthma, and pediatric IBD. J. Pediatr. Gastroenterol. Nutr. 56, 649–651 (2013).
27. Weng, X. et al. Clustering of inflammatory bowel disease with immune mediated diseases among members of a Northern California-managed care organization. Am. J. Gastroenterol. 102, 1429–1435 (2007).
28. Hemminki, K. et al. Subsequent autoimmune or related disease in asthma patients: clustering of diseases or medical care? Ann. Epidemiol. 20, 217–222 (2010).
29. Peng, Y.-H. et al. Association of inflammatory bowel disease with asthma risk: A nationwide cohort study. Allergy Asthma Proc. 36, 92–98 (2015).
30. Nakamura, Y. et al. A case-control study of ulcerative colitis in Japan. J. Clin. Gastroenterol. 18, 72–79 (1994).
31. Hemminki, K. et al. Familial association of inflammatory bowel diseases with other autoimmune and related diseases. Am. J. Gastroenterol. 105, 139–147 (2010).
32. Kuenzig, E. The association between asthma and the inflammatory bowel diseases. PROSPERO 2017;CRD42017052738 https://www.crd.york.ac.uk/prospero/display_record.asp?ID=CRD42017052738
33. Moher, D. et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS. Med. 6, e1000097–6 (2009).
34. Nama, N. et al. A pilot validation study of crowdsourcing systematic reviews: update of a searchable database of pediatric clinical trials of high-dose vitamin D. Transl. Pediatr. 5, 18–26 (2017).
35. Mortensen, M. L. et al. An exploration of crowdsourcing citation screening for systematic reviews. Res. Syn. Meth. 8, 366–386 (2017).
36. Harris, P. A. et al. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. 2009;42:377–381. http://linkinghub.elsevier.com/retrieve/pii/S1532046408001226
37. Wells, G. A. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. ohri.ca http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 30 Jan 2017.
38. Silverberg, M. S. et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can. J. Gastroenterol. 19(Suppl A), 5A–36A (2005).
39. R. Core Team. R: A language and environment for statistical computing. http://www.R-project.org/
40. Schwarzer, G. meta: An R package for meta-analysis. R. News 7, 40–45, http://CRAN.R-project.org/package=meta (2007).
41. Viechtbauer, W. Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 36:1–48. (2010).
42. Brassard, P. et al. Increased incidence of inflammatory bowel disease in Québec residents with airway diseases. Eur. Respir. J. 45, 962–968 (2015).
43. Hammer, B., Ashurst, P. & Naish, J. Diseases associated with ulcerative colitis and Crohn’s disease. Gut 9, 17–21 (1968).
44. Kappelman, M. D. et al. Association of paediatric inflammatory bowel disease with other immune-mediated diseases. Arch. Dis. Child 96, 1042–1046 (2011).
45. Livnat, G. et al. Bronchial reactivity and fractional exhaled NO in Crohn’s disease in the era of immunomodulating treatment. Acta Paediatr. 101, e399–e404 (2012).
46. Myrelid, P. et al. Atopic manifestations are more common in patients with Crohn disease than in the general population. Scand. J. Gastroenterol. 39, 731–736 (2009).
47. Neilly, J. B. et al. Pulmonary abnormalities in Crohn’s disease. Respir. Med. 83, 487–491 (1989).
48. Pugh, S. M. et al. Atopic disease in ulcerative colitis and Crohn’s disease. Clin. Allergy 9, 221–223 (1979).
49. Raj, A. A. et al. Prevalence of inflammatory bowel disease in patients with airways disease. Respir. Med. 102, 780–785 (2008).
50. D’Arienzo, A. Allergy and mucosal eosinophil infiltrate in ulcerative colitis. Scand. J. Gastroenterol. 35, 624–631 (2000).
51. D’Arienzo, A. et al. Ulcerative colitis, seronegative spondyloarthropathies and allergic diseases: the search for a link. Scand. J. Gastroenterol. 37, 1156–1163 (2002).
52. Boneberger, A. et al. Atopic manifestations in patients with ulcerative colitis: a report from Chile. J. Investig. Allergol. Clin. Immunol. 22, 73–75 (2012).
53. Virta, L. J. & Kolho, K.-L. Antidepressant use among paediatric patients with recent-onset inflammatory bowel disease: a nationwide case control study in Finland. J. Paediatr. Child Health 50, 562–565 (2014).
54. Haapamäki, J. et al. Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease. J. Crohns Colitis 5, 41–47 (2011).
55. Shen, T. C. et al. The risk of asthma in rheumatoid arthritis: a population-based cohort study. QJM 107, 435–442 (2014).
56. Hsiao, Y.-T. et al. Type 1 diabetes and increased risk of subsequent asthma. Medicine 94, e1466–e1466 (2015).
57. Edwards, L. J. & Constantinescu, C. S. A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic. Mult. Scler. 10, 575–581 (2004).
58. Yun, H. D. et al. Asthma and proinflammatory conditions: a population-based retrospective matched cohort study. Mayo Clin. Proc. 87, 953–960 (2012).
59. Pinart, M. et al. Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study. Lancet Respir. Med. 2, 131–140 (2014).
60. Mahid, S. S. et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin. Proc. 81, 1462–1471 (2006).
61. Kuenzig, M. E. et al. The NOD2-Smoking interaction in Crohn’s Disease is likely specific to the 1007fs mutation and may be explained by age at diagnosis: a meta-analysis and case-only study. EBioMedicine 21, 188–196 (2017).
62. Kaplan, G. G. et al. The inflammatory bowel diseases and ambient air pollution: a novel association. Am. J. Gastroenterol. 105, 2412–2419 (2010).
63. Altzibar, J. M. et al. Epidemiology of asthma exacerbations and their relation with environmental factors in the Basque Country. Clin. Exp. Allergy 45, 1099–1108 (2015).
64. Gross, A. et al. Use of medical care biases associations between Parkinson disease and other medical conditions. Neurology 90, e2155–e2165 (2018).
65. Du Toit, G. et al. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J. Allergy Clin. Immunol. 122, 984–991 (2008).
66. Sharifpour, A. et al. Evaluation of correlation between ulcerative colitis with asthma and air way hyper responsiveness. J. Mazand Univ. Med Sci. 20, 21–28 (2010).